According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “
Several other equities analysts have also issued reports on the company. Stifel Nicolaus started coverage on SkyWest in a research note on Monday, April 15th. They issued a buy rating and a $68.00 price target on the stock. TheStreet lowered Trade Desk from a b- rating to a c- rating in a research note on Thursday, May 9th. Boenning Scattergood set a $21.00 price target on Essential Properties Realty Trust and gave the company a buy rating in a research note on Friday, May 10th. Finally, ValuEngine lowered Zumiez from a hold rating to a sell rating in a research note on Tuesday, July 2nd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Global Medical REIT presently has an average rating of Buy and an average target price of $10.67.
Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.20 by ($0.18). Global Medical REIT had a net margin of 21.38% and a return on equity of 5.52%. The business had revenue of $15.20 million during the quarter, compared to analyst estimates of $15.32 million. As a group, equities research analysts expect that Global Medical REIT will post 0.77 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Wednesday, June 26th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Tuesday, June 25th. This represents a $0.80 annualized dividend and a dividend yield of 7.42%. Global Medical REIT’s dividend payout ratio is 102.56%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Financial Advantage Inc. bought a new stake in shares of Global Medical REIT during the first quarter valued at approximately $31,000. Daiwa Securities Group Inc. grew its holdings in Global Medical REIT by 100.0% during the first quarter. Daiwa Securities Group Inc. now owns 3,800 shares of the company’s stock worth $37,000 after buying an additional 1,900 shares in the last quarter. BNP Paribas Arbitrage SA grew its holdings in Global Medical REIT by 639.1% during the first quarter. BNP Paribas Arbitrage SA now owns 4,782 shares of the company’s stock worth $47,000 after buying an additional 4,135 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in Global Medical REIT by 19.9% during the first quarter. State of Alaska Department of Revenue now owns 7,412 shares of the company’s stock worth $72,000 after buying an additional 1,229 shares in the last quarter. Finally, Nisa Investment Advisors LLC bought a new stake in Global Medical REIT during the first quarter worth $85,000. Hedge funds and other institutional investors own 51.96% of the company’s stock.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Read More: Short Selling
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.